Amakem

Bikam Pharmaceuticals

This drug discovery company develops small-molecule therapies for patients with ophthalmic diseases such as retinitis pigmentosa.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

Kedalion Therapeutics

This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.

AsclepiX Therapeutics

This biopharmaceutical firm develops peptide therapeutics for patients with retinal diseases and cancer using a computational biology platform.

Envisia

This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Amaros AI

This company develops an artificial intelligence platform for clinical trial optimisation and data analysis for ophthalmology clinics, research organisations and therapeutic teams.